CYCN Cyclerion Therapeutics, Inc.: Rasio rega marang prakiraan pendapatan

Simbol lan logo merek Cyclerion Therapeutics, Inc. (CYCN)

Expansion risks associated with B2B licensing of sGC stimulators are creating volatility, which this forward price-to-sales ratio chart on GURU.Markets clearly illustrates for Cyclerion Therapeutics (CYCN). The value of 7.50 represents the most recent metric reading. While asset monetization and royalties could provide stabilization, the currently narrowed R&D pipeline and a period of technological stagnation limit the potential for rapid share price growth.

CYCN (Cyclerion) riwayat Rega forward marang dodolan saka 04.07.2022 nganti 09.09.2026

Rincian metrik komprehensif lan analitis Cyclerion Therapeutics, Inc. (CYCN)

- data kapitalisasi saham perusahaan:
Analisis wiwitan perusahaan:CYCN (Cyclerion Therapeutics, Inc.)
Sampel barang cyclerion.com

The calculation model for this ratio measures market expectations regarding future earnings, reflecting the balance between potential capitalization growth and the risk of asset overvaluation. Geopolitical barriers and component supply disruptions for Cyclerion Therapeutics (CYCN) therapies amplify forecast volatility; therefore, the forward price-to-sales valuation trend serves as an indicator of business model resilience amid operational uncertainty.

Pesaing wigati

Multiplikator Forward P/S BIIB (Biogen Idec)|Rasio kapitalisasi marang dodolan sing dikarepake Neurocrine Corp (NBIX)|RGC: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan AXSM (Axsome Therapeutics)|ACAD: Multiplikator Forward P/S|Xenon Pharmaceuticals Inc. - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Viking Pharma|SUPN: Rega forward marang dodolan|Multiplikator Forward P/S CPRX|Multiplikator Forward P/S denalitherapeutics.com (DNLI)|Multiplikator Forward P/S HRMY (Harmony Biosciences Inc)|Rasio kapitalisasi marang dodolan sing dikarepake Biohaven (BHVN)|Amylyx Corp - Multiplikator Forward P/S|TRVI - Multiplikator Forward P/S|Praxis Precision Medicines Inc (PRAX) - Rasio rega marang prakiraan pendapatan|AVXL - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan CeriBell|Multiplikator Forward P/S Prothena Corporation plc|Rasio rega marang prakiraan pendapatan Alector Therapeutics (ALEC)|Annexon Inc. - Kapitalisasi marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan omeros.com OMER|neurogene.com (NGNE) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|acimmune.com - Multiplikator Forward P/S|Voyager Therapeutics Inc (VYGR) - Multiplikator forward rega marang pendapatan|Neumora Corp (NMRA) - Rasio rega marang prakiraan pendapatan|Scilex Holding Company, Inc. (SCLX) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan TVGN|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Alpha Cognition Inc. ACOG|Rasio rega marang prakiraan pendapatan cogrx.com (CGTX)|Rasio kapitalisasi marang dodolan sing dikarepake Inhibikase Therapeutics, Inc.|Multiplikator Forward P/S SAVA (Cassava Sciences Inc)|Multiplikator Forward P/S Assertio Holdings, Inc. ASRT|COYA - Rasio rega marang prakiraan pendapatan|Prakiraan rega marang pendapatan Vistagen (VTGN)|OVID: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Acumen Pharmaceuticals Inc. (ABOS)|Multiplikator forward rega marang pendapatan CRVO|Kapitalisasi marang prakiraan pendapatan ATHE (Alterity Therapeutics)|Rasio rega marang prakiraan pendapatan Clene Nanomedicine (CLNN)|PEPG (PepGen) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Jupiter Neurosciences Inc JUNS|Rega forward marang dodolan RLMD|ANVS - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Grace Therapeutics Inc|AIFF: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Klotho Neurosciences Inc (KLTO)|Rasio rega marang prakiraan pendapatan neurosense-tx.com|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Reviva Pharmaceuticals Holdings Inc. RVPH|Rasio rega marang prakiraan pendapatan MetaVia Inc. (MTVA)|Rasio kapitalisasi marang dodolan sing dikarepake NeurAxis Inc|Multiplikator Forward P/S HSDT (heliusmedical.com)|Rega forward marang dodolan PASG|NEUP: Multiplikator forward rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Minerva Neurosciences Inc|Athira Pharma (ATHA) - Rasio rega marang prakiraan pendapatan|Addex Therapeutics, Ltd. - Rega forward marang dodolan|ALZN (Alzamend Neuro) - Multiplikator Forward P/S|PTIX (Protagenic Therapeutics) - Rasio rega marang pendapatan sing dikarepake|Multiplikator Forward P/S KTTA|Rasio kapitalisasi marang dodolan sing dikarepake Cortigent|Multiplikator Forward P/S ATXI (avenuetx.com)|BrainStorm Cell Therapeutics Inc. - Rasio rega marang prakiraan pendapatan|Cara Therapeutics Inc. - Multiplikator Forward P/S|Chromocell Therapeutics (CHRO) - Multiplikator forward rega marang pendapatan|ELYM: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Intra-Cellular Therapies Inc.|LBPH (Longboard Pharmaceuticals Inc) - Multiplikator Forward P/S|Marinus - Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S NKGN|NRBO (NeuroBo Pharmaceuticals) - Rega forward marang dodolan|Multiplikator Forward P/S SAGE (Sage Therapeutics Inc)|Rasio kapitalisasi marang dodolan sing dikarepake Synaptogenix Inc. (SNPX)|TRVN - Rasio rega marang prakiraan pendapatan|vigilneuro.com (VIGL) - Multiplikator forward rega marang pendapatan|WENA: Multiplikator Forward P/S|Cerevel Therapeutics, Inc. (CERE) - Multiplikator Forward P/S